Speaker Information

Mr. Thomas Viola
Mansfield, NJ
Pharmacology, Pain Control, Local Anesthesia


  • Founder and CEO, Pharmacology Declassified
  • Consultant, American Dental Association Council on Scientific Affairs; Advisory Board, Academy of General Dentistry
  • Clinical pharmacist with more than 30 years experience, specializing in the care of medically-complex patients

Sa6114 - The GLP-1 Revolution: Diabetes, Obesity Drugs and What They Mean for Dentistry
Date/Time: 3/20/2027   9:30 - 11:30 a.m.
Type: Lectures
Dentist Fee: $105.00  Other Fee: $75.00
Audience: Dentists, Hygienists, Assistants, Office Staff, Lab techs, Spouses, Physicians, Students
Keyword(s):
Communication
Dental Assisting
Diagnosis/Treatment Planning
Emergencies
Geriatric Medicine
Health and Wellness/Nutrition
Hygiene
Lab Tech Topics
Legal/Malpractice
Oral Surgery
Orthodontics
Pediatric Dentistry
Periodontics
Pharmacology
Pre-Dental
Oral Systemic Health
Credits: 2.00

Diabetes and its systemic complications are often compounded by multiple co-morbid conditions. This course offers an overview of diabetes mellitus, current treatment options, and the connection between diabetes and oral-systemic disease. Special focus is given to emerging therapies, including single-action GLP-1 (glucagon-like peptide-1) agonists such as Ozempic (semaglutide) and dual-action GLP-1/GIP (gastric inhibitory polypeptide) agonists such as Mounjaro (tirzepatide), highlighting their expanding roles in managing both diabetes and obesity for improved overall health outcomes.